Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Cancer cell or component thereof
Patent
1976-09-29
1979-05-29
Randolph, John D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Cancer cell or component thereof
42424851, 260327M, 544145, A61K 3138, C07D33322
Patent
active
041567315
ABSTRACT:
Heterocyclic oxime compounds are useful as intermediates in the preparation of pesticidally active carbamoyloxime compounds.
REFERENCES:
patent: 2690988 (1954-10-01), Jones et al.
patent: 3183148 (1965-05-01), Cannon et al.
patent: 3639471 (1972-02-01), Klauke et al.
patent: 3681386 (1972-08-01), Fridinger et al.
patent: 3956500 (1976-05-01), Durden et al.
patent: 3992549 (1976-11-01), Durden et al.
Jensen et al., Acta Chem. Scand., vol. 22, pp. 1107-1128 (1968).
Oglobin et al., J. Gen. Chem., USSR, vol. 34, pp. 1227 to 1234 (1964).
Hackh's Chemical Dictionary, 4th Ed. (McGraw-Hill, N.Y., 1969) pp. 320-321.
Brown Robert C.
Randolph John D.
Union Carbide Corporation
LandOfFree
Heterocyclic oxime compounds and carbamoyloxime derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic oxime compounds and carbamoyloxime derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic oxime compounds and carbamoyloxime derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-231031